Clinical Trials Directory

Trials / Conditions / Lung Non-Squamous Non-Small Cell Carcinoma

Lung Non-Squamous Non-Small Cell Carcinoma

9 registered clinical trials studyying Lung Non-Squamous Non-Small Cell Carcinoma — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingZipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lu
NCT07229339
Jonsson Comprehensive Cancer CenterPhase 2
RecruitingTesting the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplati
NCT05198830
National Cancer Institute (NCI)Phase 2
CompletedEvaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity
NCT04954885
Ohio State University Comprehensive Cancer Center—
RecruitingTesting the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small
NCT04267848
National Cancer Institute (NCI)Phase 3
Active Not RecruitingTargeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell
NCT03737994
National Cancer Institute (NCI)Phase 2
Active Not RecruitingTesting the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-
NCT03793179
National Cancer Institute (NCI)Phase 3
TerminatedNintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small
NCT02452463
Roswell Park Cancer InstitutePhase 2
Active Not RecruitingErlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Compl
NCT02193282
National Cancer Institute (NCI)Phase 3
CompletedErlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Can
NCT01532089
Academic and Community Cancer Research UnitedPhase 2